An agent that increases the expression of the Bcl2-associated agonist of cell death for the treatment of cancer

• 收藏
• 分享

专利权人:

LDN Pharma Limited

发明人:

Dalgleish, Angus,Lui, Wai

申请号：

AU2018244806

公开号：

AU2018244806A1

申请日:

2018.03.28

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

The present invention provides an agent that increases the expression of BAD, for use in the treatment of cancer in conjunction with a chemotherapeutic agent wherein the agent is selected from the list consisting of 6-β-naltrexol, naloxone, methylnaltrexone, or pharmaceutically acceptable salts thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/